"X2.5..","X97.5..","Estimate","Regressor","Study","N","sortby","display","Lower","Upper","regressor_type"
0.0796054896119147,0.336813235235849,1.2314709663079,"Recruitment Strategy: recruitment vendor materials","AbbVie Overall",209,"AbbVie Overall","AbbVie Overall",1.08285978396296,1.40047747946578,"Recruitment Strategy"
-0.155032005127477,-0.0108606804255935,0.920400532032211,"Recruitment Strategy: internal meetings with pi and sub is","AbbVie Overall",1195,"AbbVie Overall","AbbVie Overall",0.856387768245305,0.989198083831718,"Recruitment Strategy"
-0.0419655325845292,0.148784698032674,1.05486160974233,"Recruitment Strategy: referral local referral networks","AbbVie Overall",693,"AbbVie Overall","AbbVie Overall",0.95890283090517,1.16042312093062,"Recruitment Strategy"
-0.00431613513178122,0.187667361029323,1.09600923320644,"Recruitment Strategy: referral referring sites hospitals","AbbVie Overall",681,"AbbVie Overall","AbbVie Overall",0.995693165993008,1.20643214225115,"Recruitment Strategy"
-0.0945229737301047,0.0347956975122198,0.970577874359548,"Recruitment Strategy: internal site hospital database","AbbVie Overall",1979,"AbbVie Overall","AbbVie Overall",0.909806832729311,1.03540815072838,"Recruitment Strategy"
-0.194767491758636,0.049844069797111,0.930101358647314,"Recruitment Strategy: external database","AbbVie Overall",238,"AbbVie Overall","AbbVie Overall",0.823025996138275,1.05110718424043,"Recruitment Strategy"
0.0495831402113794,0.248258099501558,1.16058085847733,"Recruitment Strategy: other recruitment vendor abbvie run","AbbVie Overall",338,"AbbVie Overall","AbbVie Overall",1.0508329550571,1.28179071904991,"Recruitment Strategy"
-0.042902741536198,0.406412656275132,1.19932027327518,"Recruitment Strategy: patient associations","AbbVie Overall",70,"AbbVie Overall","AbbVie Overall",0.958004559587976,1.50142199584884,"Recruitment Strategy"
0.0419264851102265,0.284768386922425,1.17744570567633,"Recruitment Strategy: advertising abbvie run","AbbVie Overall",251,"AbbVie Overall","AbbVie Overall",1.04281781329617,1.32945407351023,"Recruitment Strategy"
-0.44853276938413,-0.165133918212245,0.735773211858916,"Recruitment Strategy: advertising site run","AbbVie Overall",155,"AbbVie Overall","AbbVie Overall",0.638564385835166,0.847780163281651,"Recruitment Strategy"
-0.21761328860868,0.283645034036668,1.03356694462361,"Recruitment Strategy: abbvie trial awareness program","AbbVie Overall",75,"AbbVie Overall","AbbVie Overall",0.804436466269405,1.32796146595974,"Recruitment Strategy"
-0.255233605544876,0.0603920590003038,0.907174211152984,"Barrier: Recruitment timelines","AbbVie Overall",161,"AbbVie Overall","AbbVie Overall",0.774735494312892,1.06225293073854,"Barrier"
-0.191779737264856,0.0126352273422338,0.914322198422437,"Barrier: Entry criteria","AbbVie Overall",655,"AbbVie Overall","AbbVie Overall",0.825488672861498,1.01271538909208,"Barrier"
-0.283514539287472,0.00880430353725181,0.871660628893257,"Barrier: Site resourcing","AbbVie Overall",246,"AbbVie Overall","AbbVie Overall",0.753132172055308,1.00884317541382,"Barrier"
-0.516758099329249,-0.0791366716522544,0.742340396595949,"Barrier: Site unresponsive","AbbVie Overall",113,"AbbVie Overall","AbbVie Overall",0.596451052093954,0.923913643011607,"Barrier"
-0.194006937921347,0.266512369526069,1.03691785891089,"Barrier: Change in study coordinator","AbbVie Overall",83,"AbbVie Overall","AbbVie Overall",0.823652189814643,1.30540373646102,"Barrier"
-0.779980757782986,0.00335880477740408,0.678201405766148,"Barrier: Change of PI Sub I","AbbVie Overall",28,"AbbVie Overall","AbbVie Overall",0.458414832138039,1.00336445188291,"Barrier"
-0.455088406577708,-0.259100714807865,0.69970632989092,"Barrier: Not identifying patients","AbbVie Overall",794,"AbbVie Overall","AbbVie Overall",0.63439188105391,0.771745292950583,"Barrier"
-0.66143116859287,-0.452947781558704,0.572816719279281,"Barrier: Low patient population","AbbVie Overall",715,"AbbVie Overall","AbbVie Overall",0.516112162160871,0.635751330703198,"Barrier"
-0.10947410960668,0.21927917943309,1.05643764387089,"Barrier: Screening procedures","AbbVie Overall",164,"AbbVie Overall","AbbVie Overall",0.896305369760268,1.24517885649396,"Barrier"
-0.260909685781859,0.0484976254504558,0.899239358554916,"Barrier: Study procedures","AbbVie Overall",188,"AbbVie Overall","AbbVie Overall",0.770350490075637,1.04969287926962,"Barrier"
0.0723103165699742,0.532673870295079,1.35322697699847,"Barrier: Patient travel","AbbVie Overall",83,"AbbVie Overall","AbbVie Overall",1.07498887917215,1.70348111199686,"Barrier"
-0.323962697073135,0.104364725573129,0.896014228823433,"Barrier: COVID 19","AbbVie Overall",112,"AbbVie Overall","AbbVie Overall",0.72327722223395,1.11000522838858,"Barrier"
-0.388707911712654,0.016963280352164,0.8303796146695,"Barrier: Competing studies","AbbVie Overall",114,"AbbVie Overall","AbbVie Overall",0.677932257169632,1.01710797379292,"Barrier"
-0.422958883667101,0.0340753333791781,0.823294113042221,"Barrier: Site staff out of office","AbbVie Overall",91,"AbbVie Overall","AbbVie Overall",0.65510556809669,1.03466254841836,"Barrier"
-0.25630268243289,0.0271871612901697,0.891760428338656,"Barrier: Low patient interest in the trial","AbbVie Overall",276,"AbbVie Overall","AbbVie Overall",0.773907685076303,1.02756010424207,"Barrier"
-0.49314497359698,-0.0613611962993078,0.757862669202819,"Barrier: Low site interest in the trial","AbbVie Overall",130,"AbbVie Overall","AbbVie Overall",0.610702726876899,0.940483479267313,"Barrier"
-2.56132505418821,-1.56648243215339,0.126957392216733,"Barrier: Site closure requested","AbbVie Overall",66,"AbbVie Overall","AbbVie Overall",0.0772023753078602,0.208778284012622,"Barrier"
-0.384563401250344,0.308317776922891,0.962594715291801,"Barrier: Site needs retraining","AbbVie Overall",34,"AbbVie Overall","AbbVie Overall",0.680747784964226,1.36113345702094,"Barrier"
-1.1891537306923,0.392496671831242,0.67144140316136,"Barrier: Lack of caregiver support","AbbVie Overall",8,"AbbVie Overall","AbbVie Overall",0.304478826153307,1.48067293734343,"Barrier"
-0.162074291386313,0.518301700282637,1.19496118591266,"Recruitment Strategy: recruitment vendor materials","Immunology",55,"Immunology","Immunology",0.850378026430994,1.67917348691473,"Recruitment Strategy"
-0.26243428409285,0.0617836224737072,0.904543094425085,"Recruitment Strategy: internal meetings with pi and sub is","Immunology",254,"Immunology","Immunology",0.769176909866121,1.06373215209297,"Recruitment Strategy"
-0.0505151755529418,0.395785907000199,1.18843268277722,"Recruitment Strategy: referral local referral networks","Immunology",135,"Immunology","Immunology",0.950739500565225,1.48555123738247,"Recruitment Strategy"
0.00507363708609154,0.503821930585941,1.28974920382905,"Recruitment Strategy: referral referring sites hospitals","Immunology",106,"Immunology","Immunology",1.00508652977779,1.65503462586991,"Recruitment Strategy"
-0.104126876993307,0.154848497224609,1.02568513133945,"Recruitment Strategy: internal site hospital database","Immunology",548,"Immunology","Immunology",0.901110959918728,1.16748107108331,"Recruitment Strategy"
-0.208443529052079,0.463212486461983,1.13585364537769,"Recruitment Strategy: external database","Immunology",40,"Immunology","Immunology",0.811846879170925,1.58917098386254,"Recruitment Strategy"
-0.282306925852376,0.2643295920261,0.991051610383224,"Recruitment Strategy: other recruitment vendor abbvie run","Immunology",92,"Immunology","Immunology",0.754042213963507,1.30255743810481,"Recruitment Strategy"
-0.507556692922689,0.284250837365625,0.894354609281024,"Recruitment Strategy: patient associations","Immunology",31,"Immunology","Immunology",0.601964567774645,1.32876619316514,"Recruitment Strategy"
-0.54637029220023,0.0706147239759647,0.788299027872304,"Recruitment Strategy: advertising abbvie run","Immunology",67,"Immunology","Immunology",0.579047774802863,1.07316768043186,"Recruitment Strategy"
-0.461943906634327,0.0886790293595523,0.829748663891712,"Recruitment Strategy: advertising site run","Immunology",62,"Immunology","Immunology",0.630057681006599,1.09272986582775,"Recruitment Strategy"
-1.01469755612441,0.5368312702106,0.787467528363269,"Recruitment Strategy: abbvie trial awareness program","Immunology",11,"Immunology","Immunology",0.362512052804453,1.71057790611187,"Recruitment Strategy"
-0.384709943417634,0.184869455517046,0.904909587171973,"Barrier: Recruitment timelines","Immunology",50,"Immunology","Immunology",0.680648034017478,1.20306137685064,"Barrier"
-0.639087906408169,-0.272156073961109,0.63405347023907,"Barrier: Entry criteria","Immunology",192,"Immunology","Immunology",0.527773583481903,0.761735364756074,"Barrier"
-0.834183726136265,-0.0735909965599528,0.635154272137787,"Barrier: Site resourcing","Immunology",51,"Immunology","Immunology",0.434228786417603,0.929051601445205,"Barrier"
-1.85660942086679,-0.0213720816891602,0.391022275012521,"Barrier: Site unresponsive","Immunology",8,"Immunology","Immunology",0.156201346560669,0.978854682898537,"Barrier"
-1.7433606504754,0.325311524188083,0.49212399930153,"Barrier: Change in study coordinator","Immunology",6,"Immunology","Immunology",0.174931527951049,1.38446187216923,"Barrier"
-0.915505645080258,-0.530512719377417,0.485289731326676,"Barrier: Not identifying patients","Immunology",200,"Immunology","Immunology",0.40031415802208,0.588303257858115,"Barrier"
-0.940758046589627,-0.440473144994816,0.501267395967138,"Barrier: Low patient population","Immunology",98,"Immunology","Immunology",0.390331833465901,0.643731770551647,"Barrier"
-0.331725393923917,0.387190792845016,1.02812083043616,"Barrier: Screening procedures","Immunology",34,"Immunology","Immunology",0.717684376287608,1.47283747131919,"Barrier"
-0.304809562306209,0.337132290963276,1.01629266555904,"Barrier: Study procedures","Immunology",43,"Immunology","Immunology",0.737263763834383,1.40092438111621,"Barrier"
-0.467689412582981,0.43283880803309,0.982725640293142,"Barrier: Patient travel","Immunology",22,"Immunology","Immunology",0.626448060330625,1.54162770266998,"Barrier"
-0.363720756617759,0.407124869621868,1.02193925894949,"Barrier: COVID 19","Immunology",32,"Immunology","Immunology",0.695085265605661,1.50249170952032,"Barrier"
-0.699769334844981,0.418995032328541,0.869021727408076,"Barrier: Competing studies","Immunology",13,"Immunology","Immunology",0.496699861929266,1.5204328017608,"Barrier"
-0.462845879350182,0.385275614818968,0.961957380545004,"Barrier: Site staff out of office","Immunology",24,"Immunology","Immunology",0.629489642385096,1.47001942474997,"Barrier"
-0.590126524910916,-0.062757778299545,0.721486110654782,"Barrier: Low patient interest in the trial","Immunology",86,"Immunology","Immunology",0.55425715296099,0.939170933720727,"Barrier"
-1.3837029168659,-0.229888587131964,0.446285787958094,"Barrier: Low site interest in the trial","Immunology",20,"Immunology","Immunology",0.25064870123701,0.794622128702127,"Barrier"
-186318.732440943,186267.777448136,8.6151709454621e-12,"Barrier: Site closure requested","Immunology",6,"Immunology","Immunology",0,Inf,"Barrier"
-1.12780601273992,1.43806742012586,1.16781058828701,"Recruitment Strategy: recruitment vendor materials","M20-370",12,"Immunology M20-370","   M20-370",0.323742765313552,4.21254686199523,"Recruitment Strategy"
-1.03553886098031,0.313761622305864,0.697056632773064,"Recruitment Strategy: internal meetings with pi and sub is","M20-370",46,"Immunology M20-370","   M20-370",0.355035014853579,1.3685634626582,"Recruitment Strategy"
-0.387516352237584,1.07126778459686,1.40758534655819,"Recruitment Strategy: referral local referral networks","M20-370",24,"Immunology M20-370","   M20-370",0.678740535234177,2.91907791710385,"Recruitment Strategy"
-0.534787461014811,0.971385111441136,1.24395873831915,"Recruitment Strategy: referral referring sites hospitals","M20-370",24,"Immunology M20-370","   M20-370",0.585793780930482,2.64160083806731,"Recruitment Strategy"
-0.230010507931947,0.624996827444121,1.21834473116601,"Recruitment Strategy: internal site hospital database","M20-370",75,"Immunology M20-370","   M20-370",0.794525253642174,1.86824003032693,"Recruitment Strategy"
-1.82772704599227,0.870735961420748,0.619715025879699,"Recruitment Strategy: external database","M20-370",7,"Immunology M20-370","   M20-370",0.160778595124976,2.3886681744081,"Recruitment Strategy"
-0.23779404787289,1.42700397254209,1.81231487089579,"Recruitment Strategy: other recruitment vendor abbvie run","M20-370",16,"Immunology M20-370","   M20-370",0.788365039832055,4.16619843006955,"Recruitment Strategy"
-2.05431934705695,0.833170854415516,0.543038941407305,"Recruitment Strategy: abbvie trial awareness program","M20-370",6,"Immunology M20-370","   M20-370",0.128180052021749,2.30060206119069,"Recruitment Strategy"
-1.62904275002458,0.769813564860632,0.650759854073069,"Barrier: Recruitment timelines","M20-370",7,"Immunology M20-370","   M20-370",0.196117217503406,2.1593636349947,"Barrier"
-1.19814882260705,-0.179987438333292,0.502043690368892,"Barrier: Entry criteria","M20-370",51,"Immunology M20-370","   M20-370",0.301752292221635,0.83528070386318,"Barrier"
-1.13124329528532,0.305433419844437,0.661725184942513,"Barrier: Site resourcing","M20-370",21,"Immunology M20-370","   M20-370",0.322631880263787,1.35721311864527,"Barrier"
-0.829294257979954,0.212374355097594,0.734577370375114,"Barrier: Not identifying patients","M20-370",56,"Immunology M20-370","   M20-370",0.43635713324318,1.23661072996943,"Barrier"
-0.723197384803655,0.40745340992351,0.853959092461274,"Barrier: Low patient population","M20-370",37,"Immunology M20-370","   M20-370",0.485198407143701,1.50298541969719,"Barrier"
-1.34800768322929,0.416784240442253,0.627750979008857,"Barrier: Screening procedures","M20-370",11,"Immunology M20-370","   M20-370",0.259757264211244,1.51707515415663,"Barrier"
-0.761622686123855,0.735405155581618,0.986976780385059,"Barrier: Study procedures","M20-370",15,"Immunology M20-370","   M20-370",0.466908166563941,2.0863271083648,"Barrier"
-1.00239520012052,1.02823910997417,1.01300580416249,"Barrier: Patient travel","M20-370",8,"Immunology M20-370","   M20-370",0.366999350706759,2.79613780594079,"Barrier"
-1.53431374638732,0.0634497388976321,0.47929835555889,"Barrier: COVID 19","M20-370",16,"Immunology M20-370","   M20-370",0.215603599161572,1.06550593095295,"Barrier"
-0.309889887406676,0.913701707971647,1.35243397059258,"Barrier: Low patient interest in the trial","M20-370",30,"Immunology M20-370","   M20-370",0.73352772241731,2.49353581182339,"Barrier"
-1.89795746655676,0.151054162886815,0.417507967168504,"Barrier: Low site interest in the trial","M20-370",10,"Immunology M20-370","   M20-370",0.149874430337853,1.1630596510441,"Barrier"
-0.649883527307128,0.0589449954872051,0.744182286137035,"Barrier: Entry criteria","M20-466",55,"Immunology M20-466","   M20-466",0.522106584379583,1.06071689491951,"Barrier"
-1.15395451826043,0.052868376941589,0.576636570929787,"Barrier: Site resourcing","M20-466",22,"Immunology M20-466","   M20-466",0.315387096049177,1.05429086699799,"Barrier"
-1.08859748173869,-0.373715245461828,0.481352050150022,"Barrier: Not identifying patients","M20-466",68,"Immunology M20-466","   M20-466",0.336688374312142,0.688172844271782,"Barrier"
-1.53489012540591,-0.31466780969925,0.396619075072082,"Barrier: Low patient population","M20-466",26,"Immunology M20-466","   M20-466",0.215479365576937,0.730031343325389,"Barrier"
-0.381589551273325,0.963232727190837,1.33752593192974,"Barrier: Screening procedures","M20-466",13,"Immunology M20-466","   M20-466",0.682775239928148,2.62015303714408,"Barrier"
-1.05598081928403,0.226884437337712,0.660638695812837,"Barrier: Study procedures","M20-466",17,"Immunology M20-466","   M20-466",0.347851080885884,1.25468486483866,"Barrier"
-0.971887289389568,0.654550431110909,0.85327923460009,"Barrier: Patient travel","M20-466",8,"Immunology M20-466","   M20-466",0.378368273403896,1.92427722771171,"Barrier"
-0.136365023009636,0.954708061383109,1.50556993247116,"Barrier: COVID 19","M20-466",15,"Immunology M20-466","   M20-466",0.872524082986556,2.59791204135296,"Barrier"
-0.786485629538457,0.287953558020644,0.779372604819802,"Barrier: Low patient interest in the trial","M20-466",26,"Immunology M20-466","   M20-466",0.455442579984208,1.33369536323254,"Barrier"
-1.95487222536968,-0.0177297482796234,0.372953703321003,"Barrier: Low site interest in the trial","M20-466",8,"Immunology M20-466","   M20-466",0.141582566198475,0.982426498936766,"Barrier"
-0.455937574874594,0.747962363028253,1.15721053051814,"Recruitment Strategy: recruitment vendor materials","M22-000",5,"Immunology M22-000","   M22-000",0.633853404241793,2.1126907309805,"Recruitment Strategy"
-0.503910547672154,0.123909463310883,0.826958685582255,"Recruitment Strategy: internal meetings with pi and sub is","M22-000",35,"Immunology M22-000","   M22-000",0.604163424263464,1.13191338666955,"Recruitment Strategy"
-0.532996806527423,0.290724440531773,0.885913305047819,"Recruitment Strategy: referral local referral networks","M22-000",15,"Immunology M22-000","   M22-000",0.586843674911137,1.33739600103826,"Recruitment Strategy"
0.305443659342212,1.18782423987351,2.10988606754904,"Recruitment Strategy: referral referring sites hospitals","M22-000",20,"Immunology M22-000","   M22-000",1.35722701589713,3.27993708192952,"Recruitment Strategy"
-0.0431338935214852,0.6674867239143,1.36639572473818,"Recruitment Strategy: internal site hospital database","M22-000",81,"Immunology M22-000","   M22-000",0.957783140523827,1.94933194957019,"Recruitment Strategy"
-0.805386450920665,0.278749746866729,0.768497205721035,"Recruitment Strategy: external database","M22-000",9,"Immunology M22-000","   M22-000",0.446915182399239,1.32147659882687,"Recruitment Strategy"
-1.02547725938132,0.121017250025017,0.636207822120052,"Recruitment Strategy: advertising site run","M22-000",7,"Immunology M22-000","   M22-000",0.358625267283057,1.12864438134324,"Recruitment Strategy"
-1.47790499408157,-0.395658603404486,0.391886979351944,"Barrier: Recruitment timelines","M22-000",11,"Immunology M22-000","   M22-000",0.22811509059385,0.673236497356617,"Barrier"
-1.25471568707425,-0.0895114630236641,0.510628185451532,"Barrier: Not identifying patients","M22-000",11,"Immunology M22-000","   M22-000",0.285156910495904,0.914377783530059,"Barrier"
-2.94244647433162,-0.454099182178657,0.182999322514314,"Barrier: Low patient population","M22-000",5,"Immunology M22-000","   M22-000",0.0527365521679805,0.635019747480402,"Barrier"
-1.44486126579887,-0.124717641120978,0.456215746321279,"Barrier: Competing studies","M22-000",7,"Immunology M22-000","   M22-000",0.235778784868293,0.882746118603271,"Barrier"
-1.27872631582781,0.268515313656917,0.603441908292295,"Barrier: Low patient interest in the trial","M22-000",5,"Immunology M22-000","   M22-000",0.278391657783816,1.30802100746215,"Barrier"
-0.609694975011173,0.561262539423214,0.976074642234551,"Recruitment Strategy: recruitment vendor materials","M23-696",12,"Immunology M23-696","   M23-696",0.543516629946587,1.75288418922331,"Recruitment Strategy"
-0.387110268122798,0.0125277156819931,0.829202174331182,"Recruitment Strategy: internal meetings with pi and sub is","M23-696",101,"Immunology M23-696","   M23-696",0.679016216954793,1.0126065162319,"Recruitment Strategy"
0.0591170185248443,0.621941977559432,1.40569170454817,"Recruitment Strategy: referral local referral networks","M23-696",52,"Immunology M23-696","   M23-696",1.06089937835708,1.8625415459245,"Recruitment Strategy"
-0.322816461686818,0.440573662229288,1.06064647073013,"Recruitment Strategy: referral referring sites hospitals","M23-696",27,"Immunology M23-696","   M23-696",0.724106743502684,1.55359820353353,"Recruitment Strategy"
-0.604942258298844,-0.245092264401701,0.653758500277985,"Recruitment Strategy: internal site hospital database","M23-696",214,"Immunology M23-696","   M23-696",0.546105958816413,0.782632325807308,"Recruitment Strategy"
-0.618881753063825,0.438431024105226,0.913725240852694,"Recruitment Strategy: external database","M23-696",12,"Immunology M23-696","   M23-696",0.538546328782614,1.55027296845304,"Recruitment Strategy"
-0.544674751530188,0.208449859282652,0.845258783266918,"Recruitment Strategy: other recruitment vendor abbvie run","M23-696",31,"Immunology M23-696","   M23-696",0.580030406665672,1.23176716682318,"Recruitment Strategy"
-0.186406059057378,0.846834589235431,1.39126619630528,"Recruitment Strategy: patient associations","M23-696",10,"Immunology M23-696","   M23-696",0.829936523308723,2.33225261766406,"Recruitment Strategy"
-0.733315199374619,0.144149419602151,0.744842203897184,"Recruitment Strategy: advertising abbvie run","M23-696",26,"Immunology M23-696","   M23-696",0.480314011005272,1.15505668374168,"Recruitment Strategy"
-0.525761121037382,0.179738744625008,0.841128204076202,"Recruitment Strategy: advertising site run","M23-696",31,"Immunology M23-696","   M23-696",0.591105290436315,1.19690462450476,"Recruitment Strategy"
-0.404216990665656,0.268285893019227,0.934292660504388,"Barrier: Recruitment timelines","M23-696",25,"Immunology M23-696","   M23-696",0.667499264443491,1.30772095486895,"Barrier"
-0.329209327409621,0.283936908132377,0.977618067120386,"Barrier: Entry criteria","M23-696",42,"Immunology M23-696","   M23-696",0.719492391504074,1.3283491200821,"Barrier"
-1.17897373815241,-0.510474286939242,0.429675927013451,"Barrier: Not identifying patients","M23-696",38,"Immunology M23-696","   M23-696",0.30759424891754,0.600210839131656,"Barrier"
-1.19982728068514,-0.434178730602087,0.441753605639493,"Barrier: Low patient population","M23-696",25,"Immunology M23-696","   M23-696",0.301246238462988,0.64779646408587,"Barrier"
-0.626510174608929,0.604484575427338,0.989047619289547,"Barrier: Screening procedures","M23-696",7,"Immunology M23-696","   M23-696",0.534453700359291,1.8303085797043,"Barrier"
-0.308091214537128,0.803031459341966,1.28078109514991,"Barrier: Study procedures","M23-696",7,"Immunology M23-696","   M23-696",0.734848286105697,2.23229780174986,"Barrier"
-0.913979965950157,0.649683600155341,0.876211145952553,"Barrier: Patient travel","M23-696",5,"Immunology M23-696","   M23-696",0.400925375120483,1.91493484806435,"Barrier"
-0.686408929331429,0.305334224426466,0.82651488479451,"Barrier: Site staff out of office","M23-696",12,"Immunology M23-696","   M23-696",0.503380502159982,1.35707849599978,"Barrier"
-1.49797010532822,-0.590220521724006,0.352010134175869,"Barrier: Low patient interest in the trial","M23-696",21,"Immunology M23-696","   M23-696",0.223583550883664,0.554205057003444,"Barrier"
-2.39725538847906,0.693011089607122,0.426508855346986,"Recruitment Strategy: recruitment vendor materials","M23-698",7,"Immunology M23-698","   M23-698",0.0909672808262687,1.99972783661426,"Recruitment Strategy"
-0.629039641149248,0.463035114695087,0.920349064258842,"Recruitment Strategy: internal meetings with pi and sub is","M23-698",26,"Immunology M23-698","   M23-698",0.533103525937285,1.588889134794,"Recruitment Strategy"
-0.860075801255062,0.679892669512291,0.913847504197086,"Recruitment Strategy: referral local referral networks","M23-698",22,"Immunology M23-698","   M23-698",0.423130007316493,1.97366588633973,"Recruitment Strategy"
-1.06289631971043,0.719876140863395,0.842391768729828,"Recruitment Strategy: referral referring sites hospitals","M23-698",14,"Immunology M23-698","   M23-698",0.345453815287253,2.05417876607817,"Recruitment Strategy"
-0.102900625207864,0.913877755495033,1.50003518596581,"Recruitment Strategy: internal site hospital database","M23-698",78,"Immunology M23-698","   M23-698",0.902216626616543,2.49397483127055,"Recruitment Strategy"
-0.576679312501772,1.00679558088998,1.23993397743339,"Recruitment Strategy: external database","M23-698",7,"Immunology M23-698","   M23-698",0.561760704481324,2.73681703994107,"Recruitment Strategy"
-0.505803861106003,1.12647101127296,1.36387999464262,"Recruitment Strategy: other recruitment vendor abbvie run","M23-698",14,"Immunology M23-698","   M23-698",0.603020635705903,3.08475121686148,"Recruitment Strategy"
-0.957014046088551,0.377794883782208,0.748555760812905,"Recruitment Strategy: advertising abbvie run","M23-698",19,"Immunology M23-698","   M23-698",0.38403789510717,1.45906363456611,"Recruitment Strategy"
-0.716823798055416,0.726091307200366,1.00464450701484,"Recruitment Strategy: advertising site run","M23-698",16,"Immunology M23-698","   M23-698",0.488300737264758,2.06698558582728,"Recruitment Strategy"
-0.887548711068027,1.01558640562773,1.06611249189264,"Barrier: Recruitment timelines","M23-698",6,"Immunology M23-698","   M23-698",0.411663623440374,2.76098197812749,"Barrier"
-1.19249131951216,0.0712112743139308,0.570843594106056,"Barrier: Entry criteria","M23-698",14,"Immunology M23-698","   M23-698",0.30346429501293,1.07380806996762,"Barrier"
-2.31694165970498,-0.294894322094519,0.270923715350748,"Barrier: Not identifying patients","M23-698",10,"Immunology M23-698","   M23-698",0.0985745997383529,0.744610272162181,"Barrier"
0.18320418285415,1.32105300884748,2.12151105344809,"Recruitment Strategy: recruitment vendor materials","M23-699",15,"Immunology M23-699","   M23-699",1.20105961882704,3.74736530922416,"Recruitment Strategy"
-0.771763510233914,0.351217574100347,0.810363012551802,"Recruitment Strategy: internal meetings with pi and sub is","M23-699",32,"Immunology M23-699","   M23-699",0.462197259581775,1.42079642078848,"Recruitment Strategy"
-1.27849022026555,0.841069310602865,0.803554349753049,"Recruitment Strategy: referral local referral networks","M23-699",15,"Immunology M23-699","   M23-699",0.278457392578331,2.31884521731779,"Recruitment Strategy"
-0.747285604044771,1.08380317101509,1.18324277472003,"Recruitment Strategy: referral referring sites hospitals","M23-699",17,"Immunology M23-699","   M23-699",0.473650484362232,2.95589999409025,"Recruitment Strategy"
-0.241837303335241,0.964202731291999,1.43502563616934,"Recruitment Strategy: internal site hospital database","M23-699",60,"Immunology M23-699","   M23-699",0.785183913964428,2.62269582939586,"Recruitment Strategy"
-0.204956793802684,0.895517386993129,1.41238575110714,"Recruitment Strategy: other recruitment vendor abbvie run","M23-699",20,"Immunology M23-699","   M23-699",0.814682514984503,2.4486023367869,"Recruitment Strategy"
-0.885679583492271,1.07612346583631,1.09990294178667,"Recruitment Strategy: patient associations","M23-699",10,"Immunology M23-699","   M23-699",0.412433794820939,2.93328649723334,"Recruitment Strategy"
-0.593836650630827,0.587870643195992,0.99702144101752,"Recruitment Strategy: advertising abbvie run","M23-699",13,"Immunology M23-699","   M23-699",0.552204599213025,1.80015116727627,"Recruitment Strategy"
-1.76503888752094,1.47492904748294,0.864974787374486,"Recruitment Strategy: advertising site run","M23-699",6,"Immunology M23-699","   M23-699",0.171180129584632,4.3707256479417,"Recruitment Strategy"
-0.948795655226242,0.600284947593099,0.840082352032249,"Barrier: Entry criteria","M23-699",9,"Immunology M23-699","   M23-699",0.387207073571076,1.82263808273763,"Barrier"
-2.72052651194511,-0.0159203108157637,0.2545588043376,"Barrier: Not identifying patients","M23-699",9,"Immunology M23-699","   M23-699",0.0658400797104435,0.984205747483472,"Barrier"
-2.99313480920864,0.761536194532109,0.327653278534192,"Recruitment Strategy: internal meetings with pi and sub is","M23-700",14,"Immunology M23-700","   M23-700",0.0501300420339267,2.14156355307958,"Recruitment Strategy"
-2.26172075004717,0.967095117919422,0.52345049631087,"Recruitment Strategy: referral local referral networks","M23-700",7,"Immunology M23-700","   M23-700",0.104171078054513,2.63029266093138,"Recruitment Strategy"
-0.91661119156709,0.909573725612793,0.996487450508929,"Recruitment Strategy: internal site hospital database","M23-700",40,"Immunology M23-700","   M23-700",0.399871836659515,2.48326375600015,"Recruitment Strategy"
-1.33725830626103,1.58517310014523,1.13196764468878,"Recruitment Strategy: other recruitment vendor abbvie run","M23-700",11,"Immunology M23-700","   M23-700",0.262564554242294,4.8801360576639,"Recruitment Strategy"
0.152281195052371,3.9367194816014,7.72529753830013,"Recruitment Strategy: patient associations","M23-700",6,"Immunology M23-700","   M23-700",1.16448763856054,51.250198009005,"Recruitment Strategy"
-1.98754719282321,0.369477400781566,0.445287607755603,"Barrier: Entry criteria","M23-700",19,"Immunology M23-700","   M23-700",0.137031124500312,1.44697822734613,"Barrier"
-1.90750742501117,1.55934299068077,0.840227813669562,"Barrier: Not identifying patients","M23-700",8,"Immunology M23-700","   M23-700",0.148449948452409,4.75569568210568,"Barrier"
0.0248575762181071,0.515405889434212,1.31013702741927,"Recruitment Strategy: recruitment vendor materials","Neuroscience",42,"Neuroscience","Neuroscience",1.02516910166586,1.67431795186357,"Recruitment Strategy"
-0.309584822449489,0.116100533226536,0.907790054513863,"Recruitment Strategy: internal meetings with pi and sub is","Neuroscience",53,"Neuroscience","Neuroscience",0.733751530156759,1.12310877620688,"Recruitment Strategy"
-0.314337955753054,0.162093419138934,0.926702893238306,"Recruitment Strategy: referral local referral networks","Neuroscience",53,"Neuroscience","Neuroscience",0.730272186764227,1.17597009430336,"Recruitment Strategy"
-0.124986136217049,0.444055533817385,1.17296496199143,"Recruitment Strategy: referral referring sites hospitals","Neuroscience",33,"Neuroscience","Neuroscience",0.882509137414918,1.55901706138674,"Recruitment Strategy"
-0.355385888549808,-0.0314958234550445,0.824118576420835,"Recruitment Strategy: internal site hospital database","Neuroscience",125,"Neuroscience","Neuroscience",0.700902920604553,0.968995003496482,"Recruitment Strategy"
-0.455018304936773,0.107946852172317,0.840687115916122,"Recruitment Strategy: external database","Neuroscience",22,"Neuroscience","Neuroscience",0.634436354524581,1.11398853774226,"Recruitment Strategy"
-0.161935106963246,0.202915129986881,1.02070137292867,"Recruitment Strategy: other recruitment vendor abbvie run","Neuroscience",73,"Neuroscience","Neuroscience",0.850496394043264,1.22496850074297,"Recruitment Strategy"
-0.0482227617756814,0.381519034360231,1.18133852201773,"Recruitment Strategy: advertising abbvie run","Neuroscience",54,"Neuroscience","Neuroscience",0.952921488949465,1.46450753791012,"Recruitment Strategy"
-0.398199093126572,0.077000723565536,0.851633350315857,"Recruitment Strategy: advertising site run","Neuroscience",38,"Neuroscience","Neuroscience",0.671528317679733,1.08004285787411,"Recruitment Strategy"
-0.533230055548349,0.06112099266805,0.789737607229506,"Barrier: Recruitment timelines","Neuroscience",32,"Neuroscience","Neuroscience",0.586706810160933,1.06302752494301,"Barrier"
-0.0805284974990184,0.480477708776508,1.22137174181111,"Barrier: Entry criteria","Neuroscience",69,"Neuroscience","Neuroscience",0.922628610601191,1.61684659954635,"Barrier"
-0.407697936697041,0.422785960776067,1.00757253979112,"Barrier: Site resourcing","Neuroscience",20,"Neuroscience","Neuroscience",0.665179774879073,1.52620759271534,"Barrier"
-0.954343206956661,0.0524154639826285,0.637013856125622,"Barrier: Site unresponsive","Neuroscience",12,"Neuroscience","Neuroscience",0.385064969510261,1.05381347311891,"Barrier"
-1.36470993471161,-0.0886526746932214,0.483510955937437,"Barrier: Change in study coordinator","Neuroscience",8,"Neuroscience","Neuroscience",0.255454763802138,0.915163377781476,"Barrier"
-0.721990256093496,-0.135382723560779,0.651364106447144,"Barrier: Not identifying patients","Neuroscience",49,"Neuroscience","Neuroscience",0.485784457719161,0.873381584004826,"Barrier"
-0.703013814669481,-0.0117258351208558,0.699513752292197,"Barrier: Low patient population","Neuroscience",30,"Neuroscience","Neuroscience",0.495090940715991,0.988342644561954,"Barrier"
-0.834831869795189,0.420658652614454,0.812949238550906,"Barrier: Screening procedures","Neuroscience",8,"Neuroscience","Neuroscience",0.433947434971091,1.52296432978,"Barrier"
-0.475390620211502,0.77924015543929,1.16407265717416,"Barrier: Study procedures","Neuroscience",6,"Neuroscience","Neuroscience",0.621642183031458,2.17981531525496,"Barrier"
-0.795200769697851,0.187407655816735,0.737937196983923,"Barrier: Site staff out of office","Neuroscience",12,"Neuroscience","Neuroscience",0.451490580195167,1.20611886621664,"Barrier"
-0.139474688395488,0.527891577754133,1.21434938124418,"Barrier: Low patient interest in the trial","Neuroscience",28,"Neuroscience","Neuroscience",0.86981503934004,1.69535401554679,"Barrier"
-1.63054179736482,-0.0215829173355194,0.437769677508747,"Barrier: Site needs retraining","Neuroscience",5,"Neuroscience","Neuroscience",0.195823448751777,0.97864832719311,"Barrier"
0.0248575762181071,0.515405889434212,1.31013702741927,"Recruitment Strategy: recruitment vendor materials","M21-307",42,"Neuroscience M21-307","   M21-307",1.02516910166586,1.67431795186357,"Recruitment Strategy"
-0.309584822449489,0.116100533226536,0.907790054513863,"Recruitment Strategy: internal meetings with pi and sub is","M21-307",53,"Neuroscience M21-307","   M21-307",0.733751530156759,1.12310877620688,"Recruitment Strategy"
-0.314337955753054,0.162093419138934,0.926702893238306,"Recruitment Strategy: referral local referral networks","M21-307",53,"Neuroscience M21-307","   M21-307",0.730272186764227,1.17597009430336,"Recruitment Strategy"
-0.124986136217049,0.444055533817385,1.17296496199143,"Recruitment Strategy: referral referring sites hospitals","M21-307",33,"Neuroscience M21-307","   M21-307",0.882509137414918,1.55901706138674,"Recruitment Strategy"
-0.355385888549808,-0.0314958234550445,0.824118576420835,"Recruitment Strategy: internal site hospital database","M21-307",125,"Neuroscience M21-307","   M21-307",0.700902920604553,0.968995003496482,"Recruitment Strategy"
-0.455018304936773,0.107946852172317,0.840687115916122,"Recruitment Strategy: external database","M21-307",22,"Neuroscience M21-307","   M21-307",0.634436354524581,1.11398853774226,"Recruitment Strategy"
-0.161935106963246,0.202915129986881,1.02070137292867,"Recruitment Strategy: other recruitment vendor abbvie run","M21-307",73,"Neuroscience M21-307","   M21-307",0.850496394043264,1.22496850074297,"Recruitment Strategy"
-0.0482227617756814,0.381519034360231,1.18133852201773,"Recruitment Strategy: advertising abbvie run","M21-307",54,"Neuroscience M21-307","   M21-307",0.952921488949465,1.46450753791012,"Recruitment Strategy"
-0.398199093126572,0.077000723565536,0.851633350315857,"Recruitment Strategy: advertising site run","M21-307",38,"Neuroscience M21-307","   M21-307",0.671528317679733,1.08004285787411,"Recruitment Strategy"
-0.533230055548349,0.06112099266805,0.789737607229506,"Barrier: Recruitment timelines","M21-307",32,"Neuroscience M21-307","   M21-307",0.586706810160933,1.06302752494301,"Barrier"
-0.0805284974990184,0.480477708776508,1.22137174181111,"Barrier: Entry criteria","M21-307",69,"Neuroscience M21-307","   M21-307",0.922628610601191,1.61684659954635,"Barrier"
-0.407697936697041,0.422785960776067,1.00757253979112,"Barrier: Site resourcing","M21-307",20,"Neuroscience M21-307","   M21-307",0.665179774879073,1.52620759271534,"Barrier"
-0.954343206956661,0.0524154639826285,0.637013856125622,"Barrier: Site unresponsive","M21-307",12,"Neuroscience M21-307","   M21-307",0.385064969510261,1.05381347311891,"Barrier"
-1.36470993471161,-0.0886526746932214,0.483510955937437,"Barrier: Change in study coordinator","M21-307",8,"Neuroscience M21-307","   M21-307",0.255454763802138,0.915163377781476,"Barrier"
-0.721990256093496,-0.135382723560779,0.651364106447144,"Barrier: Not identifying patients","M21-307",49,"Neuroscience M21-307","   M21-307",0.485784457719161,0.873381584004826,"Barrier"
-0.703013814669481,-0.0117258351208558,0.699513752292197,"Barrier: Low patient population","M21-307",30,"Neuroscience M21-307","   M21-307",0.495090940715991,0.988342644561954,"Barrier"
-0.834831869795189,0.420658652614454,0.812949238550906,"Barrier: Screening procedures","M21-307",8,"Neuroscience M21-307","   M21-307",0.433947434971091,1.52296432978,"Barrier"
-0.475390620211502,0.77924015543929,1.16407265717416,"Barrier: Study procedures","M21-307",6,"Neuroscience M21-307","   M21-307",0.621642183031458,2.17981531525496,"Barrier"
-0.795200769697851,0.187407655816735,0.737937196983923,"Barrier: Site staff out of office","M21-307",12,"Neuroscience M21-307","   M21-307",0.451490580195167,1.20611886621664,"Barrier"
-0.139474688395488,0.527891577754133,1.21434938124418,"Barrier: Low patient interest in the trial","M21-307",28,"Neuroscience M21-307","   M21-307",0.86981503934004,1.69535401554679,"Barrier"
-1.63054179736482,-0.0215829173355194,0.437769677508747,"Barrier: Site needs retraining","M21-307",5,"Neuroscience M21-307","   M21-307",0.195823448751777,0.97864832719311,"Barrier"
0.201777596960077,0.663386678961571,1.54123206375263,"Recruitment Strategy: recruitment vendor materials","Oncology",73,"Oncology","Oncology",1.22357585085937,1.94135596307401,"Recruitment Strategy"
-0.10982182476736,0.0984854509570173,0.99434784695761,"Recruitment Strategy: internal meetings with pi and sub is","Oncology",795,"Oncology","Oncology",0.895993764972597,1.10349834943268,"Recruitment Strategy"
-0.0524069901550695,0.228119823477732,1.09183134198362,"Recruitment Strategy: referral local referral networks","Oncology",420,"Oncology","Oncology",0.948942577953381,1.25623584296195,"Recruitment Strategy"
-0.155802407314297,0.109669312713785,0.977197451757217,"Recruitment Strategy: referral referring sites hospitals","Oncology",470,"Oncology","Oncology",0.855728259312065,1.11590899252114,"Recruitment Strategy"
-0.00529841668012448,0.184389939884399,1.09367738059638,"Recruitment Strategy: internal site hospital database","Oncology",1146,"Oncology","Oncology",0.994715595171734,1.20248462840441,"Recruitment Strategy"
-0.238570343585371,0.129186355689208,0.946776716007162,"Recruitment Strategy: external database","Oncology",138,"Oncology","Oncology",0.787753272918502,1.13790215894926,"Recruitment Strategy"
0.0885112923423052,0.437093193118745,1.30056949644637,"Recruitment Strategy: other recruitment vendor abbvie run","Oncology",93,"Oncology","Oncology",1.0925465899509,1.54820035195276,"Recruitment Strategy"
-0.381676670692051,0.437837079145576,1.02847816940988,"Recruitment Strategy: patient associations","Oncology",19,"Oncology","Oncology",0.682715759537111,1.5493524650286,"Recruitment Strategy"
-0.824255748579436,-0.127617392584822,0.621302889878273,"Recruitment Strategy: advertising abbvie run","Oncology",22,"Oncology","Oncology",0.438561270882159,0.880190081980167,"Recruitment Strategy"
-0.521739160092709,0.338958459870095,0.91266138388486,"Recruitment Strategy: advertising site run","Oncology",23,"Oncology","Oncology",0.593487480154419,1.40348504305079,"Recruitment Strategy"
-1.31490672896502,-0.333871749454295,0.438502730969071,"Recruitment Strategy: abbvie trial awareness program","Oncology",34,"Oncology","Oncology",0.268499365285062,0.716145622404684,"Recruitment Strategy"
0.131043448182681,0.744343785206061,1.5491302070694,"Barrier: Recruitment timelines","Oncology",75,"Oncology","Oncology",1.1400173119164,2.10505961038498,"Barrier"
-0.508993859891578,-0.134160649145879,0.725004617981039,"Barrier: Entry criteria","Oncology",309,"Oncology","Oncology",0.601100065547219,0.874449573741631,"Barrier"
-0.0558157252236708,0.411082530666168,1.19438738180206,"Barrier: Site resourcing","Oncology",146,"Oncology","Oncology",0.945713390958087,1.50844984479151,"Barrier"
-0.928465843201321,-0.168168398570883,0.57792156460925,"Barrier: Site unresponsive","Oncology",68,"Oncology","Oncology",0.39515948218447,0.84521149029264,"Barrier"
-0.36307463197341,0.411882990215767,1.02470439832683,"Barrier: Change in study coordinator","Oncology",47,"Oncology","Oncology",0.695534522448022,1.50965778126251,"Barrier"
-0.381121092008893,0.772142080183623,1.21593155394718,"Barrier: Change of PI Sub I","Oncology",20,"Oncology","Oncology",0.683095167245425,2.16439760487018,"Barrier"
-0.285870211715844,0.0524838652189156,0.889858183576683,"Barrier: Not identifying patients","Oncology",465,"Oncology","Oncology",0.751360127360543,1.0538855577286,"Barrier"
-0.795783399865676,-0.469221597373197,0.531260657047805,"Barrier: Low patient population","Oncology",520,"Oncology","Oncology",0.451227604778801,0.625488961086994,"Barrier"
-0.08177294162887,0.454207889368498,1.20468421923105,"Barrier: Screening procedures","Oncology",107,"Oncology","Oncology",0.921481164956776,1.57492537368619,"Barrier"
-0.20416053823028,0.278590070975316,1.03791590633733,"Barrier: Study procedures","Oncology",132,"Oncology","Oncology",0.815331468809062,1.32126560771852,"Barrier"
0.0546133825128809,0.909892287143148,1.61971925497491,"Barrier: Patient travel","Oncology",45,"Oncology","Oncology",1.05613221655002,2.48405495431852,"Barrier"
-0.0142810840920995,0.64406478967633,1.3701111292513,"Barrier: COVID 19","Oncology",79,"Oncology","Oncology",0.985820406881191,1.90420536377121,"Barrier"
-0.224011288545304,0.395266396872622,1.08940051005308,"Barrier: Competing studies","Oncology",94,"Oncology","Oncology",0.799306111315188,1.48477967890319,"Barrier"
-0.969523957038965,0.0301767935990226,0.625206313748401,"Barrier: Site staff out of office","Oncology",35,"Oncology","Oncology",0.379263540875464,1.03063672782408,"Barrier"
-0.388216589739975,0.196849260061127,0.908751440637959,"Barrier: Low patient interest in the trial","Oncology",112,"Oncology","Oncology",0.678265422022472,1.21756049187807,"Barrier"
-0.455269937270783,0.230563729158339,0.893728622575858,"Barrier: Low site interest in the trial","Oncology",94,"Oncology","Oncology",0.634276729908111,1.25930971947695,"Barrier"
-5.26379691108942,-2.19003850508761,0.0240669028499806,"Barrier: Site closure requested","Oncology",32,"Oncology","Oncology",0.00517561601039689,0.111912439336083,"Barrier"
-0.387252941199537,1.00783533930002,1.3638222000432,"Barrier: Site needs retraining","Oncology",16,"Oncology","Oncology",0.678919346532529,2.73966414837106,"Barrier"
-1.45128127575121,1.10248918446316,0.839964167624914,"Barrier: Lack of caregiver support","Oncology",5,"Oncology","Oncology",0.234269931332717,3.0116532620304,"Barrier"
-0.168427354350305,0.709310478821801,1.31054300929027,"Barrier: Entry criteria","M13-494",51,"Oncology M13-494","   M13-494",0.844992646229085,2.03258926200638,"Barrier"
0.157001375755346,1.47693244504514,2.26362364141993,"Barrier: Site resourcing","M13-494",14,"Oncology M13-494","   M13-494",1.16999722352974,4.37949072608632,"Barrier"
-0.648814561862981,0.229407740248813,0.810824692152597,"Barrier: Not identifying patients","M13-494",66,"Oncology M13-494","   M13-494",0.522664996685001,1.25785481249776,"Barrier"
-0.741242475553978,0.107865030316943,0.728557503304969,"Barrier: Low patient population","M13-494",98,"Oncology M13-494","   M13-494",0.476521481263292,1.11389739286211,"Barrier"
-1.16940696602825,0.688922619640492,0.7864373839502,"Barrier: Screening procedures","M13-494",9,"Oncology M13-494","   M13-494",0.310551053992518,1.99156869997078,"Barrier"
0.0562425541479714,1.81739050978887,2.55184475759398,"Barrier: Study procedures","M13-494",6,"Oncology M13-494","   M13-494",1.05785423955477,6.15577404085523,"Barrier"
-0.437835299723095,0.90644023369185,1.26402676075555,"Barrier: COVID 19","M13-494",18,"Oncology M13-494","   M13-494",0.645432076945518,2.47549464765918,"Barrier"
-1.45359874368383,0.853726180143844,0.740865425811395,"Barrier: Competing studies","M13-494",7,"Oncology M13-494","   M13-494",0.233727646885387,2.34838106007996,"Barrier"
-1.45389386938249,0.578214269892022,0.645429172493416,"Barrier: Low patient interest in the trial","M13-494",8,"Oncology M13-494","   M13-494",0.233658678028044,1.78285189414423,"Barrier"
-1.95420692442799,0.282122661435526,0.433422562690756,"Barrier: Low site interest in the trial","M13-494",14,"Oncology M13-494","   M13-494",0.14167679255406,1.3259413518819,"Barrier"
-3.61942573618858,0.493459543749115,0.209510149138172,"Barrier: Site closure requested","M13-494",8,"Oncology M13-494","   M13-494",0.0267980612315475,1.63797306874667,"Barrier"
NA,NA,1.27225066463493,"Recruitment Strategy: recruitment vendor materials","M14-239",17,"Oncology M14-239","   M14-239",NA,NA,"Recruitment Strategy"
NA,NA,0.764723409796891,"Recruitment Strategy: internal meetings with pi and sub is","M14-239",132,"Oncology M14-239","   M14-239",NA,NA,"Recruitment Strategy"
NA,NA,1.61253715551815,"Recruitment Strategy: referral local referral networks","M14-239",66,"Oncology M14-239","   M14-239",NA,NA,"Recruitment Strategy"
NA,NA,0.669168267807677,"Recruitment Strategy: referral referring sites hospitals","M14-239",58,"Oncology M14-239","   M14-239",NA,NA,"Recruitment Strategy"
NA,NA,0.776866939733406,"Recruitment Strategy: internal site hospital database","M14-239",172,"Oncology M14-239","   M14-239",NA,NA,"Recruitment Strategy"
NA,NA,0.661234331536372,"Recruitment Strategy: external database","M14-239",15,"Oncology M14-239","   M14-239",NA,NA,"Recruitment Strategy"
NA,NA,0.773116175053394,"Recruitment Strategy: other recruitment vendor abbvie run","M14-239",21,"Oncology M14-239","   M14-239",NA,NA,"Recruitment Strategy"
NA,NA,1.45057697383393,"Barrier: Recruitment timelines","M14-239",5,"Oncology M14-239","   M14-239",NA,NA,"Barrier"
NA,NA,1.1682568712805,"Barrier: Entry criteria","M14-239",66,"Oncology M14-239","   M14-239",NA,NA,"Barrier"
NA,NA,0.920261600414522,"Barrier: Site resourcing","M14-239",63,"Oncology M14-239","   M14-239",NA,NA,"Barrier"
NA,NA,0.591906836317636,"Barrier: Site unresponsive","M14-239",12,"Oncology M14-239","   M14-239",NA,NA,"Barrier"
NA,NA,1.26087900467948,"Barrier: Change in study coordinator","M14-239",10,"Oncology M14-239","   M14-239",NA,NA,"Barrier"
NA,NA,0.909757851251061,"Barrier: Not identifying patients","M14-239",136,"Oncology M14-239","   M14-239",NA,NA,"Barrier"
NA,NA,0.532174706501454,"Barrier: Low patient population","M14-239",96,"Oncology M14-239","   M14-239",NA,NA,"Barrier"
NA,NA,0.793956210958662,"Barrier: Screening procedures","M14-239",46,"Oncology M14-239","   M14-239",NA,NA,"Barrier"
NA,NA,0.670547893126633,"Barrier: Study procedures","M14-239",53,"Oncology M14-239","   M14-239",NA,NA,"Barrier"
NA,NA,2.49556266163635,"Barrier: Patient travel","M14-239",5,"Oncology M14-239","   M14-239",NA,NA,"Barrier"
NA,NA,1.11388590801049,"Barrier: COVID 19","M14-239",38,"Oncology M14-239","   M14-239",NA,NA,"Barrier"
NA,NA,0.886155150164878,"Barrier: Competing studies","M14-239",38,"Oncology M14-239","   M14-239",NA,NA,"Barrier"
NA,NA,1.15758877013842,"Barrier: Low patient interest in the trial","M14-239",26,"Oncology M14-239","   M14-239",NA,NA,"Barrier"
NA,NA,0.919809516625371,"Barrier: Low site interest in the trial","M14-239",45,"Oncology M14-239","   M14-239",NA,NA,"Barrier"
NA,NA,9.55235459052918e-22,"Barrier: Site closure requested","M14-239",18,"Oncology M14-239","   M14-239",NA,NA,"Barrier"
-65.2261351945086,53.8037025936202,0.00330864578918083,"Recruitment Strategy: internal site hospital database","M16-191",6,"Oncology M16-191","   M16-191",4.70597276181468e-29,2.32622191252179e+23,"Recruitment Strategy"
0.375507378504183,1.21002184219333,2.2094963869404,"Recruitment Strategy: recruitment vendor materials","M18-868",18,"Oncology M18-868","   M18-868",1.45572983329879,3.35355790080909,"Recruitment Strategy"
-0.5249964755982,-0.090691053781527,0.735030146701617,"Recruitment Strategy: internal meetings with pi and sub is","M18-868",120,"Oncology M18-868","   M18-868",0.59155744924928,0.913299827845685,"Recruitment Strategy"
-0.328914674116967,0.239262488056879,0.956163750915708,"Recruitment Strategy: referral local referral networks","M18-868",53,"Oncology M18-868","   M18-868",0.719704423542705,1.27031193453676,"Recruitment Strategy"
0.127449485063868,0.626716574769584,1.45802536407014,"Recruitment Strategy: referral referring sites hospitals","M18-868",60,"Oncology M18-868","   M18-868",1.13592748548745,1.87145569539557,"Recruitment Strategy"
-0.23064761996074,0.188933501683082,0.979358944975752,"Recruitment Strategy: internal site hospital database","M18-868",173,"Oncology M18-868","   M18-868",0.794019213265222,1.20796062246373,"Recruitment Strategy"
-0.167635543645423,0.616743748124519,1.25176443277526,"Recruitment Strategy: external database","M18-868",20,"Oncology M18-868","   M18-868",0.84566198541191,1.85288474850617,"Recruitment Strategy"
0.579279738816446,1.17226955317284,2.40073429304535,"Recruitment Strategy: other recruitment vendor abbvie run","M18-868",23,"Oncology M18-868","   M18-868",1.78475247976195,3.2293134264605,"Recruitment Strategy"
-0.378825811056111,1.27814911457692,1.56778163958277,"Barrier: Recruitment timelines","M18-868",7,"Oncology M18-868","   M18-868",0.684664863329364,3.58998891437259,"Barrier"
-1.0601424148635,-0.0801679001607318,0.565437699986266,"Barrier: Entry criteria","M18-868",27,"Oncology M18-868","   M18-868",0.34640647338636,0.922961368014514,"Barrier"
-0.634493861589696,0.604421393337396,0.985076245579446,"Barrier: Site resourcing","M18-868",15,"Oncology M18-868","   M18-868",0.530203776913044,1.83019294063619,"Barrier"
-1.21604043279061,0.858764252956017,0.836408549314961,"Barrier: Site unresponsive","M18-868",7,"Oncology M18-868","   M18-868",0.296401468004544,2.36024222847787,"Barrier"
-1.44745690806223,0.185960554237949,0.532193477144727,"Barrier: Change in study coordinator","M18-868",6,"Oncology M18-868","   M18-868",0.235167581065853,1.20437475196075,"Barrier"
-0.924202805741059,-0.125800453575997,0.591554400334356,"Barrier: Not identifying patients","M18-868",42,"Oncology M18-868","   M18-868",0.396847657680822,0.881790787427019,"Barrier"
-0.847503335811018,-0.127250772543009,0.614235389257076,"Barrier: Low patient population","M18-868",51,"Oncology M18-868","   M18-868",0.428483376722063,0.880512836465343,"Barrier"
-0.0926649642539611,0.862074448317105,1.4691804701544,"Barrier: Screening procedures","M18-868",12,"Oncology M18-868","   M18-868",0.911498833836267,2.36806803668476,"Barrier"
-1.31721563151895,-0.147460999591955,0.480783451247698,"Barrier: Study procedures","M18-868",11,"Oncology M18-868","   M18-868",0.267880141553546,0.862896090964785,"Barrier"
-1.23758886277055,0.323376775121747,0.633113198757987,"Barrier: Competing studies","M18-868",10,"Oncology M18-868","   M18-868",0.29008280485656,1.38178587538056,"Barrier"
-2.21379537598241,0.339212629044595,0.391687334523165,"Barrier: Low patient interest in the trial","M18-868",5,"Oncology M18-868","   M18-868",0.109285082422513,1.40384181102339,"Barrier"
-1.47896395233217,0.863218835329815,0.735008982686961,"Barrier: Low site interest in the trial","M18-868",6,"Oncology M18-868","   M18-868",0.227873654094729,2.37077957421941,"Barrier"
-0.282345556923578,0.664422218571422,1.21050585087867,"Recruitment Strategy: recruitment vendor materials","M19-063",13,"Oncology M19-063","   M19-063",0.754013085067694,1.94336735532903,"Recruitment Strategy"
0.304862761859298,0.75117944339555,1.69557362028266,"Recruitment Strategy: internal meetings with pi and sub is","M19-063",113,"Oncology M19-063","   M19-063",1.35643883508814,2.11949837134502,"Recruitment Strategy"
-0.338683195022201,0.247938700848777,0.955641680782644,"Recruitment Strategy: referral local referral networks","M19-063",47,"Oncology M19-063","   M19-063",0.712708202833725,1.2813813821954,"Recruitment Strategy"
-0.387719931427952,0.172024713631074,0.897764397312,"Recruitment Strategy: referral referring sites hospitals","M19-063",49,"Oncology M19-063","   M19-063",0.678602371849617,1.18770718540841,"Recruitment Strategy"
0.378389961737615,0.786565825087199,1.79046953124206,"Recruitment Strategy: internal site hospital database","M19-063",157,"Oncology M19-063","   M19-063",1.45993214956201,2.19584255560639,"Recruitment Strategy"
-0.633753610325642,0.068775350383382,0.753904836882124,"Recruitment Strategy: external database","M19-063",18,"Oncology M19-063","   M19-063",0.530596406233356,1.07119553844903,"Recruitment Strategy"
-0.49519564461935,0.146716144608522,0.840095460620899,"Recruitment Strategy: other recruitment vendor abbvie run","M19-063",10,"Oncology M19-063","   M19-063",0.609451659693641,1.15802520467433,"Recruitment Strategy"
-0.252787089596878,0.902062768424096,1.38352949538439,"Recruitment Strategy: advertising abbvie run","M19-063",6,"Oncology M19-063","   M19-063",0.776633217513688,2.46468193921265,"Recruitment Strategy"
-0.977141339783244,0.111933103938754,0.648817296108778,"Recruitment Strategy: advertising site run","M19-063",8,"Oncology M19-063","   M19-063",0.376385520730458,1.11843803904288,"Recruitment Strategy"
-0.402833639365501,0.381765994195794,0.989521463828228,"Barrier: Recruitment timelines","M19-063",30,"Oncology M19-063","   M19-063",0.668423289397017,1.46486925711408,"Barrier"
-0.659792703464,0.173019773281882,0.783968478769568,"Barrier: Entry criteria","M19-063",31,"Oncology M19-063","   M19-063",0.516958487088764,1.18888961310106,"Barrier"
-0.671178543012744,0.139778533191829,0.766669089967783,"Barrier: Site resourcing","M19-063",25,"Oncology M19-063","   M19-063",0.511105862450368,1.15001907959744,"Barrier"
-1.27134191325785,-0.142166707278082,0.493242514401798,"Barrier: Site unresponsive","M19-063",20,"Oncology M19-063","   M19-063",0.28045502283996,0.867476629763338,"Barrier"
-0.618958698276043,0.542012902207423,0.962257783463856,"Barrier: Change in study coordinator","M19-063",13,"Oncology M19-063","   M19-063",0.538504891815266,1.71946449495656,"Barrier"
-1.26038921260494,0.13914845035682,0.570854806426381,"Barrier: Change of PI Sub I","M19-063",11,"Oncology M19-063","   M19-063",0.283543646259298,1.14929470054882,"Barrier"
-0.78259063728879,-0.0421183780258151,0.662089518638753,"Barrier: Not identifying patients","M19-063",52,"Oncology M19-063","   M19-063",0.457219984544831,0.958756278179074,"Barrier"
-0.829189341819969,-0.172014083210909,0.606165812401292,"Barrier: Low patient population","M19-063",61,"Oncology M19-063","   M19-063",0.436402916559645,0.841967315481721,"Barrier"
-0.527374191112582,0.743312260660478,1.11401324918029,"Barrier: Screening procedures","M19-063",11,"Oncology M19-063","   M19-063",0.590152564794214,2.10288930927883,"Barrier"
-0.42670048881351,0.416065620220827,0.994696678232178,"Barrier: Study procedures","M19-063",26,"Oncology M19-063","   M19-063",0.65265900162875,1.51598534489982,"Barrier"
-0.440509599967217,0.51323235907888,1.03703054041956,"Barrier: Patient travel","M19-063",24,"Oncology M19-063","   M19-063",0.643708303755461,1.67068272304196,"Barrier"
-0.404766974319615,0.985311407297873,1.33679133514458,"Barrier: COVID 19","M19-063",9,"Oncology M19-063","   M19-063",0.667132251693775,2.67864590443741,"Barrier"
-0.805897870157127,0.39883986594336,0.815846542710925,"Barrier: Competing studies","M19-063",13,"Oncology M19-063","   M19-063",0.446686679813182,1.49009498454654,"Barrier"
-1.04641344203044,0.188659938052728,0.651240188293028,"Barrier: Site staff out of office","M19-063",14,"Oncology M19-063","   M19-063",0.351195074521527,1.20763021356651,"Barrier"
-0.77996385754782,0.055567301467833,0.696144324024574,"Barrier: Low patient interest in the trial","M19-063",36,"Oncology M19-063","   M19-063",0.458422579521972,1.05714016176292,"Barrier"
-1.75184887533356,-0.226209454166039,0.371937605937957,"Barrier: Low site interest in the trial","M19-063",11,"Oncology M19-063","   M19-063",0.173452953919036,0.797551033783098,"Barrier"
-1.26118214051416,0.733497079159494,0.768094481451882,"Barrier: Site needs retraining","M19-063",5,"Oncology M19-063","   M19-063",0.283318905702002,2.08235003228966,"Barrier"
-3.51331015479522,1.39746980101531,0.347177126976492,"Recruitment Strategy: internal meetings with pi and sub is","M19-753",10,"Oncology M19-753","   M19-753",0.0297981146337751,4.04495247357135,"Recruitment Strategy"
-0.960944489801164,4.42276530012838,5.64579152717513,"Recruitment Strategy: referral local referral networks","M19-753",8,"Oncology M19-753","   M19-753",0.382531418277518,83.3263895338342,"Recruitment Strategy"
-2.0186416955178,1.36600200466338,0.721574358259975,"Recruitment Strategy: referral referring sites hospitals","M19-753",11,"Oncology M19-753","   M19-753",0.132835774022428,3.91964859112715,"Recruitment Strategy"
-1.47754560582745,0.224116735331349,0.534344543653465,"Recruitment Strategy: internal site hospital database","M19-753",16,"Oncology M19-753","   M19-753",0.228197087211426,1.25121707214295,"Recruitment Strategy"
-0.509350083430296,1.13979516963629,1.37056428664982,"Recruitment Strategy: recruitment vendor materials","M20-178",13,"Oncology M20-178","   M20-178",0.600885977688577,3.12612797367272,"Recruitment Strategy"
-0.622661980843854,0.154292507953827,0.791215636029786,"Recruitment Strategy: internal meetings with pi and sub is","M20-178",124,"Oncology M20-178","   M20-178",0.536514344091981,1.16683214454876,"Recruitment Strategy"
-0.00221131581848938,0.970119223375526,1.6224769349999,"Recruitment Strategy: referral local referral networks","M20-178",88,"Oncology M20-178","   M20-178",0.997791127339139,2.63825898274594,"Recruitment Strategy"
-0.992568610170976,-0.0239775816725576,0.601533472990188,"Recruitment Strategy: referral referring sites hospitals","M20-178",110,"Oncology M20-178","   M20-178",0.370623480091922,0.976307596695961,"Recruitment Strategy"
-0.49805920025136,0.170160745453751,0.848785115814388,"Recruitment Strategy: internal site hospital database","M20-178",189,"Oncology M20-178","   M20-178",0.607708957314533,1.18549539900095,"Recruitment Strategy"
-0.13984670310644,1.01970141851222,1.55259443038889,"Recruitment Strategy: external database","M20-178",31,"Oncology M20-178","   M20-178",0.869491515531138,2.77236686294987,"Recruitment Strategy"
-0.87474884752953,0.89850447100364,1.01194863306592,"Recruitment Strategy: other recruitment vendor abbvie run","M20-178",19,"Oncology M20-178","   M20-178",0.416966728753017,2.45592745259674,"Recruitment Strategy"
-3.66085507775968,0.761014154040495,0.23458894612031,"Recruitment Strategy: advertising site run","M20-178",6,"Oncology M20-178","   M20-178",0.0257105188316121,2.1404458619549,"Recruitment Strategy"
-0.458197494961294,0.990395589807969,1.30486429573282,"Recruitment Strategy: abbvie trial awareness program","M20-178",19,"Oncology M20-178","   M20-178",0.632422563603244,2.69229930788253,"Recruitment Strategy"
-0.508465071764434,1.0324481662836,1.29951555791528,"Barrier: Recruitment timelines","M20-178",10,"Oncology M20-178","   M20-178",0.601418004178785,2.80793171060746,"Barrier"
-0.469389611326077,0.144245448857702,0.849954822224699,"Barrier: Entry criteria","M20-178",101,"Oncology M20-178","   M20-178",0.625383879042031,1.15516760830105,"Barrier"
-0.160577519583439,1.04510994452568,1.55622997312148,"Barrier: Site resourcing","M20-178",12,"Oncology M20-178","   M20-178",0.851651801320102,2.8437111569396,"Barrier"
-0.798866920395379,0.243864972692728,0.757674826739981,"Barrier: Site unresponsive","M20-178",22,"Oncology M20-178","   M20-178",0.449838378151053,1.27617200078623,"Barrier"
-0.491463777503717,1.25315256482302,1.46351985472184,"Barrier: Change in study coordinator","M20-178",6,"Oncology M20-178","   M20-178",0.611730301450619,3.50136385280556,"Barrier"
-0.0719521223849345,0.577550811155302,1.28762488174898,"Barrier: Not identifying patients","M20-178",81,"Oncology M20-178","   M20-178",0.930575448477771,1.78166943777766,"Barrier"
-0.691702499764108,-0.0698719550763731,0.683323266607479,"Barrier: Low patient population","M20-178",124,"Oncology M20-178","   M20-178",0.500722862424926,0.932513215845267,"Barrier"
-0.380625341197612,1.06768513110821,1.40991567121881,"Barrier: Screening procedures","M20-178",8,"Oncology M20-178","   M20-178",0.683433896184404,2.90863858384343,"Barrier"
-0.41834447113786,0.744450301343283,1.17709897435368,"Barrier: Study procedures","M20-178",15,"Oncology M20-178","   M20-178",0.658135480695144,2.1052838451454,"Barrier"
-0.909930381533011,0.834473327065314,0.962974326714234,"Barrier: Patient travel","M20-178",7,"Oncology M20-178","   M20-178",0.402552248128525,2.30360048471189,"Barrier"
-0.763426507205741,0.480125263529223,0.867924437364898,"Barrier: Competing studies","M20-178",13,"Oncology M20-178","   M20-178",0.466066706919272,1.6162768500554,"Barrier"
-0.792014840590424,0.879182470943388,1.04454753957954,"Barrier: Site staff out of office","M20-178",7,"Oncology M20-178","   M20-178",0.4529312909589,2.40892953130207,"Barrier"
-0.598553381945,0.533177986236596,0.967840771145536,"Barrier: Low patient interest in the trial","M20-178",21,"Oncology M20-178","   M20-178",0.549606131442699,1.70434008047315,"Barrier"
-0.568680936825771,0.624525224052574,1.02831562036623,"Barrier: Low site interest in the trial","M20-178",15,"Oncology M20-178","   M20-178",0.566271894682883,1.86735916971715,"Barrier"
-0.654596653532292,0.0573290006366117,0.741830998599451,"Recruitment Strategy: internal meetings with pi and sub is","M20-621",80,"Oncology M20-621","   M20-621",0.519651619967445,1.05900416613256,"Recruitment Strategy"
-0.266299178831927,0.607566689354251,1.18605628259258,"Recruitment Strategy: referral local referral networks","M20-621",50,"Oncology M20-621","   M20-621",0.766209859435896,1.83595850164732,"Recruitment Strategy"
-0.512253248309867,0.351177842285848,0.922620117370622,"Recruitment Strategy: referral referring sites hospitals","M20-621",50,"Oncology M20-621","   M20-621",0.599144036416363,1.42073997109008,"Recruitment Strategy"
-0.180864033324102,0.480839827547559,1.16182018126335,"Recruitment Strategy: internal site hospital database","M20-621",135,"Oncology M20-621","   M20-621",0.834548821811189,1.61743219607131,"Recruitment Strategy"
-0.275024932489116,0.920990265307145,1.3812414088245,"Recruitment Strategy: external database","M20-621",13,"Oncology M20-621","   M20-621",0.759553185437358,2.51177648389814,"Recruitment Strategy"
-1.49671186610665,0.563080558752085,0.626995664104293,"Barrier: Recruitment timelines","M20-621",7,"Oncology M20-621","   M20-621",0.223865049535868,1.75607386512827,"Barrier"
-1.0603669709565,0.249846347805454,0.666803211669924,"Barrier: Not identifying patients","M20-621",18,"Oncology M20-621","   M20-621",0.346328694435304,1.28382813852111,"Barrier"
-1.18603381566705,0.276341000569598,0.634545421850733,"Barrier: Low patient population","M20-621",13,"Oncology M20-621","   M20-621",0.305430257638828,1.31829732752888,"Barrier"
-0.816999337250824,0.798425309804993,0.990755977399714,"Barrier: Study procedures","M20-621",8,"Oncology M20-621","   M20-621",0.441755226168208,2.22203914884642,"Barrier"
-1.10883488364084,0.666376218273329,0.801532841533218,"Barrier: Low patient interest in the trial","M20-621",7,"Oncology M20-621","   M20-621",0.329943159386453,1.94716840697953,"Barrier"
-0.30817003696094,0.397037905734051,1.0454359070644,"Recruitment Strategy: internal meetings with pi and sub is","M20-638",80,"Oncology M20-638","   M20-638",0.734790365865388,1.48741231043819,"Recruitment Strategy"
-0.459037293052689,0.423846435005759,0.982558466596035,"Recruitment Strategy: referral local referral networks","M20-638",32,"Oncology M20-638","   M20-638",0.631891679290392,1.52782695503082,"Recruitment Strategy"
-0.094560178470591,0.728326330525168,1.37284204439515,"Recruitment Strategy: referral referring sites hospitals","M20-638",47,"Oncology M20-638","   M20-638",0.909772984231873,2.07161051330878,"Recruitment Strategy"
-0.292655501158955,0.433463402299099,1.07294150906106,"Recruitment Strategy: internal site hospital database","M20-638",129,"Oncology M20-638","   M20-638",0.746279188733919,1.54259089526436,"Recruitment Strategy"
-0.092523103868625,0.901136023783125,1.49826303423403,"Recruitment Strategy: external database","M20-638",17,"Oncology M20-638","   M20-638",0.911628148584172,2.46239886650989,"Recruitment Strategy"
-4.39663965090032,-0.319891625916407,0.0945841240955152,"Barrier: Entry criteria","M20-638",5,"Oncology M20-638","   M20-638",0.0123186654463972,0.726227737074579,"Barrier"
-1.13907267856472,-0.1004565709869,0.538071071289907,"Barrier: Not identifying patients","M20-638",19,"Oncology M20-638","   M20-638",0.320115734403352,0.904424389818548,"Barrier"
-1.50397283483252,-0.524544958487879,0.362671107030078,"Barrier: Low patient population","M20-638",27,"Oncology M20-638","   M20-638",0.222245459424565,0.591824607868159,"Barrier"
-1.23459531044156,0.572601991166205,0.718207568110063,"Barrier: Screening procedures","M20-638",5,"Oncology M20-638","   M20-638",0.290952483978159,1.7728740577767,"Barrier"
-1.38125263997324,0.500012272260773,0.643637123923585,"Barrier: Study procedures","M20-638",6,"Oncology M20-638","   M20-638",0.251263613002219,1.64874150436166,"Barrier"
-1.40012605931503,1.02854926054209,0.830449299973017,"Recruitment Strategy: internal site hospital database","M21-103",12,"Oncology M21-103","   M21-103",0.246565880056493,2.79700516416815,"Recruitment Strategy"
-2.21597694562526,0.031114050030731,0.335399993894299,"Recruitment Strategy: other recruitment vendor abbvie run","M21-103",11,"Oncology M21-103","   M21-103",0.109046929272577,1.03160315154867,"Recruitment Strategy"
-0.230704991768792,2.092797601436,2.53716243463698,"Barrier: COVID 19","M21-103",5,"Oncology M21-103","   M21-103",0.793973660254071,8.10756520269596,"Barrier"
-1.38020586264996,-0.0311897078251978,0.493763912851069,"Recruitment Strategy: internal meetings with pi and sub is","M22-132",40,"Oncology M22-132","   M22-132",0.251526767762662,0.969291673417629,"Recruitment Strategy"
-0.390077540558731,1.316214882953,1.58894245325009,"Recruitment Strategy: referral local referral networks","M22-132",16,"Oncology M22-132","   M22-132",0.677004377165186,3.72927887159643,"Recruitment Strategy"
-0.947822425147714,0.694050376193151,0.880834060398634,"Recruitment Strategy: referral referring sites hospitals","M22-132",26,"Oncology M22-132","   M22-132",0.387584098577973,2.00180720727442,"Recruitment Strategy"
-0.435756537668952,0.625110398845649,1.09930364636839,"Recruitment Strategy: internal site hospital database","M22-132",54,"Oncology M22-132","   M22-132",0.646775172159628,1.86845222101473,"Recruitment Strategy"
-1.55537904714021,0.842583127663146,0.700193915794706,"Barrier: Site resourcing","M22-132",5,"Oncology M22-132","   M22-132",0.211109347079022,2.32235818309081,"Barrier"
-1.24499233739104,0.544982637883774,0.704684672163377,"Barrier: Not identifying patients","M22-132",10,"Oncology M22-132","   M22-132",0.287943114517806,1.72457843978519,"Barrier"
-0.564542254011854,1.31917333136827,1.45836440715547,"Barrier: Screening procedures","M22-132",6,"Oncology M22-132","   M22-132",0.568620370888273,3.74032808697212,"Barrier"
-1.75463028635514,0.350332591160937,0.495519363336563,"Recruitment Strategy: internal meetings with pi and sub is","M22-137",14,"Oncology M22-137","   M22-137",0.172971180277131,1.41953959641181,"Recruitment Strategy"
-5.93645435067985,-0.312480728423952,0.0439603345322489,"Recruitment Strategy: referral local referral networks","M22-137",9,"Oncology M22-137","   M22-137",0.00264137846917715,0.731629728468733,"Recruitment Strategy"
-0.79193103130249,1.00258824858589,1.11107565943655,"Recruitment Strategy: internal site hospital database","M22-137",18,"Oncology M22-137","   M22-137",0.452969252398617,2.72532653034472,"Recruitment Strategy"
-1.98451996105824,2.67760025294163,1.41416626572723,"Barrier: Not identifying patients","M22-137",5,"Oncology M22-137","   M22-137",0.137446577992921,14.5501347237899,"Barrier"
-0.521043448571052,3.37907145688266,4.17458104245864,"Barrier: Low patient population","M22-137",11,"Oncology M22-137","   M22-137",0.593900519893915,29.3435117436299,"Barrier"
-0.458343229016779,0.636702604227056,1.09327708701924,"Recruitment Strategy: internal meetings with pi and sub is","M22-947",43,"Oncology M22-947","   M22-947",0.63233040481377,1.89023772999386,"Recruitment Strategy"
-1.01577726444862,0.149343361179838,0.648419800808401,"Recruitment Strategy: referral local referral networks","M22-947",30,"Oncology M22-947","   M22-947",0.362120856750238,1.16107158768377,"Recruitment Strategy"
-0.368861172688842,0.772070399774755,1.22336421083322,"Recruitment Strategy: referral referring sites hospitals","M22-947",28,"Oncology M22-947","   M22-947",0.691521405844145,2.1642424655252,"Recruitment Strategy"
-1.27983876507902,0.171145349358276,0.574447420623262,"Recruitment Strategy: internal site hospital database","M22-947",45,"Oncology M22-947","   M22-947",0.278082133389581,1.18666321722445,"Recruitment Strategy"
-1.41307437614779,0.016408781281911,0.497413902613768,"Recruitment Strategy: external database","M22-947",8,"Oncology M22-947","   M22-947",0.243393847480937,1.01654414470291,"Recruitment Strategy"
-1.26723864146931,0.964744521466565,0.859635290925404,"Barrier: Recruitment timelines","M22-947",5,"Oncology M22-947","   M22-947",0.281608170243792,2.62411716522523,"Barrier"
-1.78970278196868,0.130065417035812,0.436128356870867,"Barrier: Entry criteria","M22-947",6,"Oncology M22-947","   M22-947",0.167009800615219,1.13890288453856,"Barrier"
-1.02272443658401,0.205106748361219,0.664441232037594,"Barrier: Not identifying patients","M22-947",14,"Oncology M22-947","   M22-947",0.359613859179381,1.22765610824642,"Barrier"
-1.54792461817334,-0.0377608010175928,0.452556478350979,"Barrier: Low patient population","M22-947",12,"Oncology M22-947","   M22-947",0.212688926829019,0.962943248390573,"Barrier"
-1.56133321565393,1.05153900920315,0.774996238471765,"Recruitment Strategy: recruitment vendor materials","M23-362",6,"Oncology M23-362","   M23-362",0.209856101172866,2.86205245541388,"Recruitment Strategy"
-1.18065636725519,0.709596209443353,0.79015189574683,"Recruitment Strategy: internal meetings with pi and sub is","M23-362",34,"Oncology M23-362","   M23-362",0.307077117075019,2.03317011797979,"Recruitment Strategy"
-1.19779048060539,0.659853078417087,0.7641671728703,"Recruitment Strategy: referral local referral networks","M23-362",21,"Oncology M23-362","   M23-362",0.301860442118202,1.9345080925308,"Recruitment Strategy"
-0.934961566386606,0.734140525108962,0.904466039835501,"Recruitment Strategy: referral referring sites hospitals","M23-362",26,"Oncology M23-362","   M23-362",0.392600954314855,2.08369034314587,"Recruitment Strategy"
-0.419279929220902,2.50326749348455,2.83486348372622,"Recruitment Strategy: internal site hospital database","M23-362",40,"Oncology M23-362","   M23-362",0.657520110411419,12.2223652845171,"Recruitment Strategy"
-65.5931652676866,49.545182903812,0.000327510257772317,"Recruitment Strategy: abbvie trial awareness program","M23-362",7,"Oncology M23-362","   M23-362",3.2602452712907e-29,3.29002759058139e+21,"Recruitment Strategy"
-0.760475221724297,1.08505691422003,1.17620228559894,"Barrier: Entry criteria","M23-362",8,"Oncology M23-362","   M23-362",0.46744423456359,2.95960825774174,"Barrier"
-1.70104381562472,-0.0118418960358787,0.42467001122194,"Barrier: Not identifying patients","M23-362",19,"Oncology M23-362","   M23-362",0.182492935622845,0.988227943266568,"Barrier"
-2.42191343995434,-0.506577074976645,0.231252461698053,"Barrier: Low patient population","M23-362",18,"Oncology M23-362","   M23-362",0.0887516339622054,0.602554552000506,"Barrier"
-0.429906834977782,0.329750898322253,0.951155261624381,"Recruitment Strategy: recruitment vendor materials","Specialty",39,"Specialty","Specialty",0.650569702240786,1.39062167912163,"Recruitment Strategy"
-0.349932228014201,0.206980914389248,0.931018941287683,"Recruitment Strategy: internal meetings with pi and sub is","Specialty",93,"Specialty","Specialty",0.70473584944829,1.22995909703617,"Recruitment Strategy"
-0.436467957030227,0.202801962574881,0.889733768762814,"Recruitment Strategy: referral local referral networks","Specialty",85,"Specialty","Specialty",0.646315207413074,1.22482988207167,"Recruitment Strategy"
-0.257551682798701,0.378536003068368,1.06235926878425,"Recruitment Strategy: referral referring sites hospitals","Specialty",72,"Specialty","Specialty",0.772941677492033,1.46014537556547,"Recruitment Strategy"
0.114090847547712,0.626972947261167,1.44850486577631,"Recruitment Strategy: internal site hospital database","Specialty",160,"Specialty","Specialty",1.12085394709137,1.87193554666279,"Recruitment Strategy"
-0.225149006079616,0.536394239402567,1.16838519077578,"Recruitment Strategy: external database","Specialty",38,"Specialty","Specialty",0.798397243852322,1.70983049420027,"Recruitment Strategy"
-0.0473585046439123,0.493667391868576,1.2500136154468,"Recruitment Strategy: other recruitment vendor abbvie run","Specialty",80,"Specialty","Specialty",0.953745414132628,1.6383135537521,"Recruitment Strategy"
-0.734939973108575,0.432409040957501,0.859619468560098,"Recruitment Strategy: patient associations","Specialty",17,"Specialty","Specialty",0.479534243060919,1.54096530418928,"Recruitment Strategy"
-0.171599006610935,0.360844906829554,1.09924430703255,"Recruitment Strategy: advertising abbvie run","Specialty",108,"Specialty","Specialty",0.842316868953034,1.4345409561195,"Recruitment Strategy"
-0.679224131481403,-0.0167718090077475,0.706100309423863,"Recruitment Strategy: advertising site run","Specialty",32,"Specialty","Specialty",0.507010213065007,0.983368054766481,"Recruitment Strategy"
-0.317845350376625,0.434914096698761,1.06028143029262,"Recruitment Strategy: abbvie trial awareness program","Specialty",26,"Specialty","Specialty",0.727715320613097,1.54483034722455,"Recruitment Strategy"
-0.298888862112596,0.457366351648377,1.08246272353477,"Barrier: Entry criteria","Specialty",85,"Specialty","Specialty",0.741641829361063,1.57990757998611,"Barrier"
-0.900213399830926,0.150146283567518,0.687266215033826,"Barrier: Site resourcing","Specialty",29,"Specialty","Specialty",0.406482907100779,1.16200421241776,"Barrier"
-0.644758035810458,0.56393677769508,0.960394992081543,"Barrier: Site unresponsive","Specialty",25,"Specialty","Specialty",0.524789507013238,1.75757809271907,"Barrier"
-0.414296662822068,0.626267797357485,1.11180582999483,"Barrier: Change in study coordinator","Specialty",22,"Specialty","Specialty",0.660804885942405,1.87061601678022,"Barrier"
-0.819070855227936,-0.105246632366407,0.6299223357411,"Barrier: Not identifying patients","Specialty",80,"Specialty","Specialty",0.440841069448658,0.900102500798731,"Barrier"
-1.2379263895392,-0.399743325022929,0.440945119313238,"Barrier: Low patient population","Specialty",67,"Specialty","Specialty",0.28998491066668,0.670492122501003,"Barrier"
-0.0915806702296479,1.01128163033978,1.58383715204554,"Barrier: Screening procedures","Specialty",15,"Specialty","Specialty",0.912487702590321,2.74912211647195,"Barrier"
-0.0749859936539758,1.61374653925194,2.1584282025458,"Barrier: Study procedures","Specialty",7,"Specialty","Specialty",0.927756480715846,5.02158961147909,"Barrier"
-0.20133661432405,1.02965883421401,1.5131008828481,"Barrier: Patient travel","Specialty",15,"Specialty","Specialty",0.817637156846884,2.8001103698672,"Barrier"
-0.732577485318878,0.507619091295473,0.89361593679703,"Barrier: Site staff out of office","Specialty",20,"Specialty","Specialty",0.480668476133238,1.66133100494046,"Barrier"
-0.217297290711066,0.70112367853337,1.27368362452339,"Barrier: Low patient interest in the trial","Specialty",50,"Specialty","Specialty",0.80469070666911,2.0160167899716,"Barrier"
-1.0459104992919,0.639630288440764,0.816163884426416,"Barrier: Low site interest in the trial","Specialty",13,"Specialty","Specialty",0.351371749959156,1.89577985799783,"Barrier"
-2.56867517857958,-0.971638514966651,0.170306274740821,"Barrier: Site closure requested","Specialty",24,"Specialty","Specialty",0.0766370085493331,0.378462413462095,"Barrier"
-0.833218138261848,0.963575760902521,1.06734986155977,"Barrier: Site needs retraining","Specialty",9,"Specialty","Specialty",0.434648274962423,2.62105199214271,"Barrier"
-0.542567451137143,0.359057869225736,0.91232883340064,"Recruitment Strategy: recruitment vendor materials","M18-969",29,"Specialty M18-969","   M18-969",0.581253993749588,1.43197966672855,"Recruitment Strategy"
-0.231243212196975,0.404239312260826,1.0903492415695,"Recruitment Strategy: internal meetings with pi and sub is","M18-969",60,"Specialty M18-969","   M18-969",0.793546442389686,1.49816243270027,"Recruitment Strategy"
-0.461379624680418,0.395915041494056,0.967797612469125,"Recruitment Strategy: referral local referral networks","M18-969",46,"Specialty M18-969","   M18-969",0.630413311514415,1.48574308567645,"Recruitment Strategy"
-0.453534389976315,0.423324349723548,0.985008488454985,"Recruitment Strategy: referral referring sites hospitals","M18-969",33,"Specialty M18-969","   M18-969",0.635378502983731,1.52702950724982,"Recruitment Strategy"
0.0141175168904563,0.668361377894732,1.40669002879865,"Recruitment Strategy: internal site hospital database","M18-969",100,"Specialty M18-969","   M18-969",1.01421763963874,1.95103768637506,"Recruitment Strategy"
-0.600850600095832,0.441949061033378,0.923623489266706,"Recruitment Strategy: external database","M18-969",15,"Specialty M18-969","   M18-969",0.548345015345732,1.5557364908065,"Recruitment Strategy"
-0.089622737870461,0.53587771003495,1.24997991862135,"Recruitment Strategy: other recruitment vendor abbvie run","M18-969",60,"Specialty M18-969","   M18-969",0.914276041943027,1.7089475445907,"Recruitment Strategy"
-1.18141660173532,0.663066727425047,0.771688014329146,"Recruitment Strategy: patient associations","M18-969",6,"Specialty M18-969","   M18-969",0.306843755178678,1.94073492260741,"Recruitment Strategy"
-0.172211895055742,0.44397336403259,1.14554526140563,"Recruitment Strategy: advertising abbvie run","M18-969",88,"Specialty M18-969","   M18-969",0.841800780845561,1.55888896255331,"Recruitment Strategy"
-0.692935179012892,0.0149128407499107,0.712474491323474,"Recruitment Strategy: advertising site run","M18-969",25,"Specialty M18-969","   M18-969",0.500106012010485,1.01502459197791,"Recruitment Strategy"
-0.516851598887823,0.30429673666186,0.899175154305033,"Recruitment Strategy: abbvie trial awareness program","M18-969",22,"Specialty M18-969","   M18-969",0.596395286790929,1.35567127377871,"Recruitment Strategy"
-0.22028985133431,0.736609039638643,1.29454540401508,"Barrier: Entry criteria","M18-969",60,"Specialty M18-969","   M18-969",0.802286220526149,2.08884031681055,"Barrier"
-1.05941540421522,0.153833514188799,0.635851047565117,"Barrier: Site resourcing","M18-969",20,"Specialty M18-969","   M18-969",0.346658406148949,1.16629669876212,"Barrier"
-0.445496358028558,1.01693030655539,1.33071577513728,"Barrier: Site unresponsive","M18-969",14,"Specialty M18-969","   M18-969",0.640506276685309,2.7646949587494,"Barrier"
-0.509002915764172,0.632968039886439,1.06394379157948,"Barrier: Change in study coordinator","M18-969",17,"Specialty M18-969","   M18-969",0.601094622086257,1.88319168072356,"Barrier"
-0.892416939909337,0.0381905479990693,0.652389700172872,"Barrier: Not identifying patients","M18-969",44,"Specialty M18-969","   M18-969",0.409664420951796,1.0389291798951,"Barrier"
-1.02222440517837,0.219957078249146,0.669560559272389,"Barrier: Low patient population","M18-969",31,"Specialty M18-969","   M18-969",0.359793722367747,1.2460232479402,"Barrier"
-0.197158427207643,0.988329774842977,1.48525381050875,"Barrier: Screening procedures","M18-969",12,"Specialty M18-969","   M18-969",0.821060544678741,2.68674325654499,"Barrier"
-0.227892812892597,1.68739631213121,2.0745655320598,"Barrier: Study procedures","M18-969",6,"Specialty M18-969","   M18-969",0.796209598665529,5.40538842287748,"Barrier"
-0.35644621231349,0.966844147495029,1.35689495426954,"Barrier: Patient travel","M18-969",14,"Specialty M18-969","   M18-969",0.700160130450421,2.62963261809507,"Barrier"
-0.734297738969822,0.644003159198685,0.955856683442741,"Barrier: Site staff out of office","M18-969",16,"Specialty M18-969","   M18-969",0.479842315239159,1.90408801030142,"Barrier"
-0.577098879941503,0.565781049182332,0.994357066121852,"Barrier: Low patient interest in the trial","M18-969",42,"Specialty M18-969","   M18-969",0.561525057419177,1.76082253477846,"Barrier"
-0.681370295958461,1.21808485772896,1.30781431360958,"Barrier: Low site interest in the trial","M18-969",10,"Specialty M18-969","   M18-969",0.505923252571435,3.38070699496183,"Barrier"
-2.71499460862842,-0.918229276087366,0.16257563451017,"Barrier: Site closure requested","M18-969",19,"Specialty M18-969","   M18-969",0.0662053099435373,0.39922533342002,"Barrier"
-1.07409626948064,1.18071022309986,1.05475338025482,"Barrier: Site needs retraining","M18-969",5,"Specialty M18-969","   M18-969",0.341606335914505,3.25668635559908,"Barrier"
-0.949581131384622,0.864142279970946,0.958180193086056,"Recruitment Strategy: recruitment vendor materials","M20-350",10,"Specialty M20-350","   M20-350",0.386903051063277,2.37296986906489,"Recruitment Strategy"
-0.952598435628982,0.421777551230981,0.766891120892652,"Recruitment Strategy: internal meetings with pi and sub is","M20-350",33,"Specialty M20-350","   M20-350",0.385737406281968,1.52466932614277,"Recruitment Strategy"
-0.651897205372705,0.444661771844102,0.901569886605134,"Recruitment Strategy: referral local referral networks","M20-350",39,"Specialty M20-350","   M20-350",0.521056287637384,1.55996248336007,"Recruitment Strategy"
-0.344297614105874,0.705058955345349,1.19767319535285,"Recruitment Strategy: referral referring sites hospitals","M20-350",39,"Specialty M20-350","   M20-350",0.708717972193738,2.02396600501983,"Recruitment Strategy"
-0.227562567686714,0.72232779185789,1.28066901849448,"Recruitment Strategy: internal site hospital database","M20-350",60,"Specialty M20-350","   M20-350",0.79647258649121,2.05922107395686,"Recruitment Strategy"
-0.183145403737958,1.07954363503664,1.56549037825526,"Recruitment Strategy: external database","M20-350",23,"Specialty M20-350","   M20-350",0.832647076937263,2.94333600908616,"Recruitment Strategy"
-0.182795170704098,1.17492755176047,1.64224825550073,"Recruitment Strategy: other recruitment vendor abbvie run","M20-350",20,"Specialty M20-350","   M20-350",0.832938748522684,3.23790835458023,"Recruitment Strategy"
-0.821795508958027,0.741905819036361,0.960842432992896,"Recruitment Strategy: patient associations","M20-350",11,"Specialty M20-350","   M20-350",0.43964156504355,2.09993379708822,"Recruitment Strategy"
-1.05402101486019,0.430484359802821,0.732151127842938,"Recruitment Strategy: advertising abbvie run","M20-350",20,"Specialty M20-350","   M20-350",0.348533469428673,1.53800228965209,"Recruitment Strategy"
-1.6766395625585,0.439684840065015,0.53876415655201,"Recruitment Strategy: advertising site run","M20-350",7,"Specialty M20-350","   M20-350",0.187001327624126,1.55221794450913,"Recruitment Strategy"
-1.06454682344778,0.204195614457245,0.650394872431339,"Barrier: Entry criteria","M20-350",25,"Specialty M20-350","   M20-350",0.344884112751451,1.22653805856761,"Barrier"
-1.30744558096501,0.798308577583922,0.775250945271454,"Barrier: Site resourcing","M20-350",9,"Specialty M20-350","   M20-350",0.270510170918334,2.22177978041989,"Barrier"
-1.29692234098659,1.04700314493322,0.882532557921172,"Barrier: Site unresponsive","M20-350",11,"Specialty M20-350","   M20-350",0.273371844996951,2.84909997150428,"Barrier"
-1.26638663600342,1.53071039880901,1.14129305843521,"Barrier: Change in study coordinator","M20-350",5,"Specialty M20-350","   M20-350",0.281848204184672,4.62145873520962,"Barrier"
-1.18612398257095,0.0229025734883744,0.55899726162544,"Barrier: Not identifying patients","M20-350",36,"Specialty M20-350","   M20-350",0.305402719179684,1.02316685111403,"Barrier"
-1.95823510169926,-0.700132202645541,0.264693254888489,"Barrier: Low patient population","M20-350",36,"Specialty M20-350","   M20-350",0.141107241215444,0.496519658239865,"Barrier"
-1.11294978949536,1.10315898285564,0.995116559637844,"Barrier: Low patient interest in the trial","M20-350",8,"Specialty M20-350","   M20-350",0.328588263893739,3.01367113825372,"Barrier"
-8317.07178878059,8278.88767526627,5.11004944241037e-09,"Barrier: Site closure requested","M20-350",5,"Specialty M20-350","   M20-350",0,Inf,"Barrier"
